Switch to: References

Add citations

You must login to add citations.
  1. Accès aux médicaments : quelle responsabilité pour les compagnies pharmaceutiques?Caroline Allard - 2004 - Dialogue 43 (4):645-670.
    The moral responsibility of pharmaceutical companies is often invoked when discussing the difficulties faced by developing countries regarding their access to medication. In this article, I wish to criticize one strategy of attributing responsibility to pharmaceuticals, according to which moral responsibility originates from the analogy between enterprise and individual moral agent. I will propose an alternative strategy linking responsibility to the functions of the enterprise using a distinction between the organizational and occupational functions of a pharmaceutical company. Despite its interest, (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Introduction.Janet Malek - 2006 - Journal of Medicine and Philosophy 31 (5):441 – 446.
    Download  
     
    Export citation  
     
    Bookmark  
  • Who's in the Business of Saving Lives?Pepe Lee Chang - 2006 - Journal of Medicine and Philosophy 31 (5):465-482.
    There are individuals, including children, dying needlessly in poverty-stricken third world countries. Many of these deaths could be prevented if pharmaceutical companies provided the drugs needed to save their lives. Some believe that because pharmaceutical companies have the power to save lives, and because they can do so with little effort, they have a special obligation. I argue that there is no distinction, with respect to obligations and responsibilities, between pharmaceutical companies and other types of companies. As a result, to (...)
    Download  
     
    Export citation  
     
    Bookmark   7 citations  
  • Restoring a reputation: invoking the UNESCO Universal Declaration on Bioethics and Human Rights to bear on pharmaceutical pricing.Daniel J. Hurst - 2017 - Medicine, Health Care and Philosophy 20 (1):105-117.
    In public health, the issue of pharmaceutical pricing is a perennial problem. Recent high-profile examples, such as the September 2015 debacle involving Martin Shkreli and Turing Pharmaceuticals, are indicative of larger, systemic difficulties that plague the pharmaceutical industry in regards to drug pricing and the impact it yields on their reputation in the eyes of the public. For public health ethics, the issue of pharmaceutical pricing is rather crucial. Simply, individuals within a population require pharmaceuticals for disease prevention and management. (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • Why Bioethics Must be Global.Heather Widdows & Peter G. N. West-Oram - 2013 - In John Coggon & Swati Gola (eds.), Global Health and International Community: Ethical, Political and Regulatory Challenges. Bloomsbury Academic. pp. 43-62.
    This chapter considers what type of bioethics is necessary to address contemporary issues in global health. It explores what kind of ethics, or bioethics, is needed to adequately address such concerns, and argues that because the most pressing ethical dilemmas are global, a global framework must be adopted. Moreover, it argues that to adopt a local model of ethics (whether one community, one nation state or one area of jurisdiction) will fail to illuminate key issues of injustice and thus will (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation